NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft

NovaBay Pharmaceuticals, Inc. and BioStem Technologies, Inc. announce an agreement under which NovaBay has been granted the right to commercialize BioStem Technologies’ Amniotic Tissue Allograft,...

Related Keywords

United States ,China ,American ,Avenova Allograft ,Biostem Technologie ,Justin Hall ,Jason Matuszewski ,American Association Of Tissue Banks ,China Pioneer Pharma Holdings ,Exchange Commission ,Novabay Pharmaceuticals Inc ,Novabay Pharmaceuticals Forward ,Biostem Technologies Inc ,Novabay Pharmaceuticals ,Biostem Technologies ,Biostem Technologie Amniotic Tissue Allograft ,Tissue Allograft ,General Counsel ,Bay Pharmaceuticals ,Antimicrobial Lid ,Flash Solution ,Astem Technologies ,Stem Technologie ,American Association ,Tissue Banks ,Good Tissue Practices ,Good Manufacturing Processes ,Each Biostem Technologies ,Pompano Beach ,Private Securities Litigation Reform Act ,Registration Statement ,Stem Technologies Forward Looking Statements ,Markets ,